Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at NOK 2.03T, ahead of Johnson & Johnson (NOK 1.94T) and Merck & Co (NOK 1.33T). Figures as of 20 Nov 2026, 13:26 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerNOK 2.03T
- Median
- NOK 14.5B
- Combined market value
- NOK 36.41T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 2.03T | NOK 1.53T | NOK 268.43 | 1.85% down | 10% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 1.94T | NOK 6.27T | NOK 2,603.81 | 2.04% down | 31% up | ||
| 3 | Merck & CoMRK · Health Care | NOK 1.33T | NOK 3.19T | NOK 1,294.50 | 3.61% down | 36% up | ||
| 4 | AbbVieABBV · Health Care | NOK 1.31T | NOK 4.89T | NOK 2,763.66 | 0.86% down | 20% up | ||
| 5 | Eli LillyLLY · Health Care | NOK 1.1T | NOK 11.73T | NOK 13,169.37 | 2.29% down | 28% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | NOK 877.6B | NOK 1.16T | NOK 568.64 | 2.05% down | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | NOK 845.2B | NOK 1.75T | NOK 1,012.42 | 0.58% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | NOK 395.3B | NOK 931B | NOK 8,999.79 | 2.35% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | NOK 362.5B | NOK 222.1B | NOK 193.77 | 1.97% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | NOK 249.9B | NOK 1.29T | NOK 5,074.87 | 2.94% down | 22% up | ||
| 11 | Royalty PharmaRPRX · Health Care | NOK 191.2B | NOK 379.5B | NOK 660.07 | 1.38% down | 74% up | ||
| 12 | ZoetisZTS · Health Care | NOK 150.8B | NOK 320B | NOK 787.46 | 5.59% down | 34% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | NOK 130.2B | NOK 128.1B | NOK 256.25 | 1.54% down | 18% up | ||
| 14 | United TherapeuticsUTHR · Health Care | NOK 76.8B | NOK 232.1B | NOK 5,449.55 | 3.16% down | 18% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | NOK 74B | NOK 116B | NOK 598.66 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | NOK 48.4B | NOK 193B | NOK 1,440.80 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.9B | NOK 72.6B | NOK 208.49 | 2.24% down | 79% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | NOK 34.3B | NOK 44.2B | NOK 265.31 | 0.62% down | 64% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | NOK 28.3B | NOK 47.5B | NOK 568.49 | 3.16% down | 26% down | ||
| 20 | InsmedINSM · Health Care | NOK 22.1B | NOK 308.9B | NOK 1,408.05 | 20.58% up | 27% down | ||
| 21 | Legend BiotechLEGN · Health Care | NOK 16.9B | NOK 30.4B | NOK 156.93 | 0.92% down | 43% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | NOK 15.2B | NOK 55.9B | NOK 2,796.80 | 3.94% down | 44% up | ||
| 23 | CytokineticsCYTK · Health Care | NOK 13.9B | NOK 69.9B | NOK 501.58 | 0.27% up | 21% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 13.5B | NOK 60.1B | NOK 425.46 | 1.25% up | 8% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 12.3B | NOK 89.8B | NOK 3,867.02 | 0.34% down | 28% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | NOK 10.4B | NOK 95.6B | NOK 632.39 | 1.88% down | 103% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | NOK 9.1B | NOK 84.7B | NOK 3,030.34 | 1.87% up | 83% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | NOK 9.1B | NOK 47B | NOK 270.38 | 0.25% down | 25% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | NOK 9.1B | NOK 148.4B | NOK 762.02 | 0.22% up | 15% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | NOK 8.2B | NOK 60.8B | NOK 930.94 | 3.27% up | 35% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | NOK 8.2B | NOK 69.3B | NOK 633.36 | 4.15% down | 16% down | ||
| 32 | Belite BioBLTE · Health Care | NOK 7.6B | NOK 59.8B | NOK 1,471.99 | 3.33% down | 25% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | NOK 7.6B | NOK 90.4B | NOK 951.60 | 3.77% down | 302% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | NOK 7.3B | NOK 82.4B | NOK 103.03 | 0.67% up | 35% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | NOK 6.7B | NOK 69.6B | NOK 1,322.47 | 1.25% up | 9% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | NOK 6.5B | NOK 78.9B | NOK 1,208.82 | 2.47% down | 45% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | NOK 5.9B | NOK 45.2B | NOK 470.78 | 3.86% down | 39% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.4B | NOK 43.9B | NOK 401.28 | 0.48% down | 82% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | NOK 5.2B | NOK 46.6B | NOK 826.84 | 1.01% up | 105% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | NOK 4.8B | NOK 64.5B | NOK 951.01 | 1.91% up | 233% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 4.7B | NOK 78.9B | NOK 1,138.45 | 1.88% down | 15% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | NOK 4.3B | NOK 39.3B | NOK 287.34 | 1.24% up | 176% up | ||
| 43 | ErascaERAS · Health Care | NOK 3.9B | NOK 48.6B | NOK 138.60 | 3.34% up | 387% up | ||
| 44 | VeradermicsMANE · Health Care | NOK 1.5B | NOK 51.2B | NOK 1,212.43 | 0.38% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7470 NOK).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (NOK 2.03T), Johnson & Johnson (NOK 1.94T) and Merck & Co (NOK 1.33T) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 13:26 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of NOK 36.41T as of 20 Nov 2026, 13:26 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.